Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,195,000 | 2,331,000 | 3,910,000 | 3,308,000 | 1,073,000 |
| Depreciation Amortization | 2,517,000 | 1,261,000 | 4,025,000 | 2,303,000 | 1,205,000 |
| Income taxes - deferred | -222,000 | -284,000 | 631,000 | -155,000 | 47,000 |
| Accounts receivable | N/A | N/A | 207,000 | N/A | N/A |
| Other Working Capital | -3,702,000 | -2,841,000 | -1,260,000 | -1,300,000 | -214,000 |
| Other Operating Activity | 1,386,000 | 1,116,000 | 4,214,000 | 3,173,000 | 2,345,000 |
| Operating Cash Flow | $5,174,000 | $1,583,000 | $11,727,000 | $7,329,000 | $4,456,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,413,000 | -1,990,000 | 2,129,000 | -426,000 | -1,518,000 |
| PPE Investments | -961,000 | -472,000 | -2,629,000 | -1,862,000 | -1,204,000 |
| Net Acquisitions | -868,000 | -1,443,000 | 7,391,000 | 7,389,000 | 7,376,000 |
| Purchase Of Investment | -712,000 | -453,000 | -1,883,000 | -1,240,000 | -843,000 |
| Sale Of Investment | 1,429,000 | 816,000 | 356,000 | 351,000 | N/A |
| Other Investing Activity | -245,000 | -179,000 | -514,000 | -273,000 | 22,000 |
| Investing Cash Flow | $-6,770,000 | $-3,721,000 | $4,850,000 | $3,939,000 | $3,833,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,360,000 | 1,776,000 | 194,000 | 814,000 | 189,000 |
| Debt Issued | 1,588,000 | 1,524,000 | 600,000 | 600,000 | 621,000 |
| Debt Repayment | -11,000 | -3,000 | -439,000 | -436,000 | -274,000 |
| Common Stock Issued | 786,000 | 586,000 | 1,072,000 | 927,000 | 725,000 |
| Common Stock Repurchased | -2,275,000 | -912,000 | -13,037,000 | -9,873,000 | -6,422,000 |
| Dividend Paid | -2,562,000 | -1,282,000 | -4,353,000 | -3,276,000 | -2,089,000 |
| Other Financing Activity | -170,000 | -106,000 | -946,000 | -280,000 | -718,000 |
| Financing Cash Flow | $716,000 | $1,583,000 | $-16,909,000 | $-11,524,000 | $-7,968,000 |
| Exchange Rate Effect | 12,000 | N/A | -26,000 | -26,000 | -23,000 |
| Beginning Cash Position | 1,520,000 | 1,520,000 | 1,878,000 | 1,878,000 | 1,878,000 |
| End Cash Position | 652,000 | 965,000 | 1,520,000 | 1,610,000 | 2,190,000 |
| Net Cash Flow | $-868,000 | $-555,000 | $-358,000 | $-268,000 | $312,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,174,000 | 1,583,000 | 11,727,000 | 7,329,000 | 4,456,000 |
| Capital Expenditure | -961,000 | -472,000 | -2,629,000 | -1,862,000 | -1,204,000 |
| Free Cash Flow | 4,213,000 | 1,111,000 | 9,098,000 | 5,467,000 | 3,252,000 |